Smart-Money SignalNeutral · 44/100— Insiders are net buyers over 90 days ($404K, 15 buys vs 7 sales)
Revenue$5.3B
Net Income$670.0M
EPS$1.94
Gross Margin69.6%
Market Cap$66.0B
Price Performance
Historical data including institutional events
Company Profile
M
Michael F. Mahoney
CEO & Executive Director
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.